| Nov 25 | Feb 26 | May 26 | Aug 26 | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Buy | — | — | — | — | — | — | — | — | — | — | — | — |
| Sell | — | 1 | 4 | — | 1 | — | — | 1 | — | — | — | 1 |
| total | individual payouts | |
|---|---|---|
| 2025 | ‡‡‡‡ |
|
| 2024 | ‡‡‡‡ |
|
| 2023 | ‡‡‡‡ |
|
| 2022 | ‡‡‡‡ |
|
| 2021 | ‡‡‡‡ |
|
| 2020 | ‡‡‡‡ |
|
| 2019 | ‡‡‡‡ |
|
| 2018 | ‡‡‡ |
|
| 2023 | 2024 | 2025 | 2026 | |
|---|---|---|---|---|
| Cash | 550.47 | 858.60 | 934.24 | 875.06 |
| Receivables | 531.77 | 592.45 | 758.89 | 1,017.93 |
| Inventory | 519.58 | 463.21 | 581.02 | 1,021.24 |
| Other | 42.88 | 87.81 | 116.21 | 195.57 |
| 1,652.54 | 2,012.69 | 2,428.84 | 3,159.71 |
| 2023 | 2024 | 2025 | 2026 | |
|---|---|---|---|---|
| Payables | 381.13 | 441.84 | 637.42 | 1,005.76 |
| ST’ Debt | 12.16 | — | — | — |
| Other | 81.00 | — | — | 2.32 |
| 481.89 | 557.94 | 809.84 | 1,402.63 |
| 10y | 5y | 3y | |
| Sales | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
| Cash Flow | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
| Earnings | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
| Book Value | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
| Sep | Dec | Mar | Jun | Year | |
|---|---|---|---|---|---|
| ’26 | — | — | — | — |
—
|
| ’26 | 978.13 | 1,132.89 | 1,214.29 | 1,315.79 |
4,641.10
|
| ’25 | 804.23 | 833.61 | 871.80 | 909.69 |
3,419.33
|
| ’24 | 685.48 | 712.69 | 731.54 | 753.26 |
2,882.97
|
| ’23 | 655.43 | 668.66 | 665.28 | 655.87 |
2,645.24
|
| ’22 | 543.32 | 566.63 | 564.40 | 587.87 |
2,262.22
|
| ’21 | 436.64 | 453.83 | 479.32 | 509.57 |
1,879.35
|
| Sep | Dec | Mar | Jun | Year | |
|---|---|---|---|---|---|
| ’26 | — | — | — | — |
—
|
| ’26 | 102.57 | 46.26 | 52.93 | 54.97 |
256.73
|
| ’25 | 83.18 | 115.90 | 74.19 | 55.09 |
328.37
|
| ’24 | 145.05 | 84.17 | 100.87 | 83.06 |
413.15
|
| ’23 | 60.63 | 44.47 | 37.12 | 71.09 |
213.31
|
| ’22 | 36.91 | 20.66 | 50.33 | 16.35 |
124.25
|
| ’21 | 34.51 | 6.81 | 38.00 | 42.84 |
122.16
|
| Sep | Dec | Mar | Jun | Year | |
|---|---|---|---|---|---|
| ’26 | — | — | — | — |
—
|
| ’26 | 57.15 | (5.40) | (11.25) | (36.07) |
4.43
|
| ’25 | 62.85 | 93.97 | 45.39 | 4.60 |
206.80
|
| ’24 | 133.75 | 75.76 | 87.30 | 70.61 |
367.42
|
| ’23 | 50.37 | 30.70 | 17.14 | 52.95 |
151.17
|
| ’22 | 4.22 | 1.17 | 26.81 | 1.72 |
33.93
|
| ’21 | 21.43 | (4.05) | 26.80 | 30.10 |
74.27
|
| Sep | Dec | Mar | Jun | Year | |
|---|---|---|---|---|---|
| ’26 | — | — | — | — |
—
|
| ’26 | 2.66 | 3.11 | 3.45 | 3.83 |
13.05
|
| ’25 | 2.13 | 2.38 | 2.25 | 2.42 |
9.17
|
| ’24 | 1.78 | 1.89 | 2.21 | 2.22 |
8.10
|
| ’23 | 1.76 | 1.71 | 1.60 | 1.65 |
6.73
|
| ’22 | 1.20 | 1.30 | 1.35 | 1.51 |
5.36
|
| ’21 | 0.88 | 0.94 | 1.00 | 1.13 |
3.95
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡‡ | 74.57 | 90.19 | 159.69 | 148.55 | 373.70 | — | — | — |
Low Price
|
| ‡‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 136.08 | 199.99 | 278.38 | 531.22 | 748.89 | — | — | — |
High Price
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 14,235 | 14,663 | 14,213 | 16,457 | 21,521 | — | — | — |
Employees
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 0.16 | 0.18 | 0.20 | 0.21 | 0.22 | — | — | — |
Revenue/Emp
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 2,262.22 | 2,645.24 | 2,882.97 | 3,419.33 | 4,641.10 | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
Revenue
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 12.32% | 12.71% | 12.35% | 12.09% | 11.99% | — | — | — |
Gross Margin
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 206.97 | 260.10 | 311.35 | 355.18 | 555.11 | — | — | — |
EBT
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 9.15% | 9.83% | 10.80% | 10.39% | 11.96% | ‡‡‡ | ‡‡‡ | ‡‡‡ |
EBT Margin
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 200.38 | 247.91 | 296.18 | 332.53 | 473.03 | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
Net Income
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 41.49 | 43.53 | 45.40 | 48.87 | 63.65 | — | — | — |
Depreciation
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 61.35 | 72.44 | 79.54 | 94.94 | 129.59 | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
Revenue/Sh
|
| ‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡ | 5.43 | 6.79 | 8.17 | 9.23 | 13.21 | ‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
Earnings/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 3.37 | 5.84 | 11.40 | 9.12 | 7.17 | — | — | — |
Cash Flow/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (2.45) | (1.70) | (1.26) | (3.38) | (7.04) | ‡‡‡ | ‡‡‡ | ‡‡‡ |
Capex/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 0.92 | 4.14 | 10.14 | 5.74 | 0.12 | — | — | — |
Free CF/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 34.00 | 40.22 | 48.16 | 55.02 | 68.53 | — | — | — |
Book Value/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 36.88 | 36.52 | 36.25 | 36.02 | 35.82 | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
Shares
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 14.94 | 19.13 | 29.73 | 31.89 | 42.58 | ‡‡‡‡ | ‡‡‡‡ | — |
PE Ratio
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 1.32 | 1.79 | 3.05 | 3.10 | 4.34 | ‡‡‡ | ‡‡‡ | ‡‡‡ |
PS Ratio
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 2.39 | 3.23 | 5.04 | 5.36 | 8.20 | ‡‡‡ | ‡‡‡ | ‡‡‡ |
PB Ratio
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 1.12 | 1.59 | 2.76 | 2.83 | 4.15 | ‡‡‡ | ‡‡‡ | ‡‡‡‡ |
EV/Sales
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 74.86 | 27.81 | 21.64 | 46.84 | 4,350.24 | — | — | — |
EV/FCF
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 124.25 | 213.31 | 413.15 | 328.37 | 256.73 | ‡‡‡ | ‡‡‡ | ‡‡‡ |
Op' Cash Flow
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (90.32) | (62.14) | (45.72) | (121.56) | (252.30) | ‡‡‡‡‡ | — | — |
Capex
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 33.93 | 151.17 | 367.42 | 206.80 | 4.43 | — | — | — |
FCF
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 986.68 | 1,170.66 | 1,454.75 | 1,619.00 | 1,757.08 | — | — | — |
Working Cap'
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 27.36 | 12.16 | — | — | — | — | — | — |
Total Debt
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (451.01) | (538.31) | (858.60) | (934.24) | (875.05) | — | — | — |
Net Debt
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 1,253.68 | 1,468.66 | 1,745.75 | 1,981.81 | 2,454.26 | — | — | — |
Sh' Equity
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 11.61% | 13.00% | 13.72% | 12.86% | 14.03% | — | — | — |
ROA
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 15.92% | 16.91% | 19.56% | 19.36% | 18.32% | — | — | — |
ROIC
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 16.94% | 18.21% | 18.43% | 17.84% | 21.33% | — | — | — |
ROE
|
Fabrinet (FN), a key contract manufacturer of optical, electro-mechanical, and electronic components, has delivered resilient growth amid surging data center, AI, and photonics demand, fueled by U.S.-China trade tensions shifting supply chains to its Thailand facilities. Partnerships with hyperscalers like Apple, Cisco, and Coherent propelled revenue from under $1 billion in 2016 to nearly $2.9 billion in 2024 (15%+ CAGR), with impressive productivity gains—revenue per employee doubling to over $202,000—despite steady gross margins around 12%. Explosive free cash flow ($367 million in 2024, up 143% YoY) and a debt-free balance sheet with net cash exceeding $900 million underscore its status as a high-quality compounder boasting elite ROIC (19.6%) and ROE (18.4%).
Analysts forecast accelerating revenue to $6.1 billion by 2028 (17% CAGR from 2024), driven by AI optical transceiver demand from cloud giants’ capex boom, with EBT margins expanding and EPS surging 116% to $17.64. Yet, the stock trades at rich multiples (29.7x 2024 PE, 3.1x PS), having appreciated over 500% in highs since 2016, amid volatility tied to tech cycles.
Insider selling ($40 million, no buys) tempers enthusiasm despite Wall Street’s 11% average upside targets, highlighting risks from competition, margin pressures, and macro wildcards. Fabrinet’s moat in a fragmented market positions it for outsized gains if AI tailwinds persist, but caution is warranted at current valuations—delve deeper for the full breakdown.
Keep track of companies that you follow and research.
Full access to our data with predictions and indicators that we calculate daily.
Full access to our screener with tons of custom values and customizable email notifications.
Excel export of financials and screeners you define and save.